Cas:17288-32-3 Ethyl 1H-pyrrolo[3,2-b]pyridine-2-carboxylate manufacturer & supplier

We serve Chemical Name:Ethyl 1H-pyrrolo[3,2-b]pyridine-2-carboxylate CAS:17288-32-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Ethyl 1H-pyrrolo[3,2-b]pyridine-2-carboxylate

Chemical Name:Ethyl 1H-pyrrolo[3,2-b]pyridine-2-carboxylate
CAS.NO:17288-32-3
Synonyms:Ethyl 1H-pyrrolo[3,2-b]pyridine-2-carboxylate;1H-Pyrrolo[3,2-b]pyridine-2-carboxylic acid, ethyl ester;1H-Pyrrolo[3,2-b]Pyridine-2-Carboxylic Acid Ethyl Ester
Molecular Formula:C10H10N2O2
Molecular Weight:190.199
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:355.9±22.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.628
PSA:54.98000
Exact Mass:190.074234
LogP:1.74

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Ethyl 1H-pyrrolo[3,2-b]pyridine-2-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-Pyrrolo[3,2-b]Pyridine-2-Carboxylic Acid Ethyl Ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-Pyrrolo[3,2-b]pyridine-2-carboxylic acid, ethyl ester Use and application,1H-Pyrrolo[3,2-b]Pyridine-2-Carboxylic Acid Ethyl Ester technical grade,usp/ep/jp grade.


Related News: Novadiscovery (NOVA), a leading health tech company using in silico clinical trials to predict drug efficacy and optimize clinical trial development, today announces the appointment of Grégoire Boutonnet as Chief Operating Officer, effective immediately. trimethyl(6-trimethylsilyloxyhexa-1,5-dienoxy)silane manufacturers CHMP on Friday also announced that Roche pulled its Tecentriq application in triple-negative breast cancer after it noted that the EMA said the results from a late-stage trial do not favor the drug’s benefit-risk calculation in this indication. 4,8-dimethylnona-1,3,7-trien-2-yloxy(trimethyl)silane suppliers Immunocompromised people account for roughly 2.7% of U.S. adults including patients who’ve received an organ transplant, living with HIV or have received active or recent treatment for cancer, Oliver said. N,N-dimethyl[(4-formylphenyl)thio]formamide vendor & factory.